1527-3350/asset/cover.gif?v=1&s=3cd983af6575c8dbfd6b47a63ffa95415ace15f8 "Hepatology")
Direct Link:
1527-3350/asset/olbannerleft.gif?v=1&s=4b2409f9534ed500d3c8da1940a23842e2b9932d)
1527-3350/asset/olbannerright.gif?v=1&s=141b9a8485298533c3e2016e937b0404f7d933e1)
Original Article
You have full text access to this OnlineOpen article
Improvement in pulmonary hemodynamics during intravenous epoprostenol (prostacyclin): A study of 15 patients with moderate to severe portopulmonary hypertension
Article first published online: 30 DEC 2003
DOI: 10.1002/hep.510300307
Copyright © 1999 American Association for the Study of Liver Diseases
Additional Information
How to Cite
Krowka, M. J., Frantz, R. P., McGoon, M. D., Severson, C., Plevak, D. J. and Wiesner, R. H. (1999), Improvement in pulmonary hemodynamics during intravenous epoprostenol (prostacyclin): A study of 15 patients with moderate to severe portopulmonary hypertension. Hepatology, 30: 641–648. doi: 10.1002/hep.510300307
Publication History
- Issue published online: 30 DEC 2003
- Article first published online: 30 DEC 2003
- Manuscript Accepted: 8 JUN 1999
- Manuscript Received: 27 JAN 1999
- Abstract
- References
- Cited By
Cited in:
- CrossRef
This article has been cited by:
- 1, , , , , , , , Treatment with sildenafil and treprostinil allows successful liver transplantation of patients with moderate to severe portopulmonary hypertension, Liver Transplantation, 2012, 18, 6
- You have free access to this content2, , , , , , , , , , Current management approaches to portopulmonary hypertension, International Journal of Clinical Practice, 2011, 65,Direct Link:
- 3, , , , , Living-donor liver transplantation for moderate or severe porto-pulmonary hypertension accompanied by pulmonary arterial hypertension: a single-centre experience over 2 decades in Japan, Journal of Hepato-Biliary-Pancreatic Sciences, 2011,
- 4, Management of Pulmonary Complications in Pretransplant Patients, Clinics in Liver Disease, 2011, 15, 4, 765
- 5, , Medical Management of Chronic Liver Diseases (CLD) in Children (Part II), Pediatric Drugs, 2011, 13, 6, 371
- 6, , , , , , Portopulmonary hypertension: From diagnosis to treatment, European Journal of Internal Medicine, 2011, 22, 5, 441
- 7, , , , , , Successful treatment of portopulmonary hypertension with the selective endothelin receptor antagonist Sitaxentan, Wiener klinische Wochenschrift, 2011, 123, 7-8, 248
- 8
- 9, , , , , Usefulness of acute pulmonary vasoreactivity test of sildenafil in treatment of portopulmonary hypertension. A case report, Journal of Cardiology Cases, 2011, 4, 1, e31
- 10
- 11, , , Critical care management of patients before liver transplantation, Transplantation Reviews, 2010, 24, 4, 190
- 12, , , , , , , Functional improvement in a patient with cirrhosis and portopulmonary hypertension treated by sildenafil for 2 years, Respiratory Medicine CME, 2010, 3, 4, 263
- 13, , Portopulmonary hypertension: short review, European Journal of Gastroenterology & Hepatology, 2010, 22, 4, 385
- 14
- 15, , , , , , , Successful outcomes following living donor liver transplantation for portopulmonary hypertension, Liver Transplantation, 2010, 16, 8Direct Link:
- 16, , , , , , , , , , , , , , , , , , GuÃa de práctica clÃnica para el diagnóstico y tratamiento de la hipertensión pulmonar, Revista Española de CardiologÃa, 2009, 62, 12, 1464.e1
- 17, , , , , , , , , , , , , , , , , , GuÃa de práctica clÃnica para el diagnóstico y tratamiento de la hipertensión pulmonar, Revista Española de CardiologÃa (English Edition), 2009, 62, 12, 1464.e1
- 18, , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Guidelines for the diagnosis and treatment of pulmonary hypertension: The Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT), European Heart Journal, 2009, 30, 20, 2493
- 19, , , , , , , , , Hemodynamic Profile of Portopulmonary Hypertension, Transplantation Proceedings, 2009, 41, 4, 1235
- 20, , Hepatopulmonary syndrome and portopulmonary hypertension, Hepatology Research, 2009, 39, 10Direct Link:
- 21, , , HTAP et maladies hépatiques, Revue des Maladies Respiratoires Actualités, 2009, 1, 3, 175
- 22, , , , , Initial experience using continuous intravenous treprostinil to manage pulmonary arterial hypertension in patients with end-stage liver disease, Transplant International, 2009, 22, 5Direct Link:
- 23, , , , , , , , , Rapid Normalization of Portopulmonary Hypertension After Living Donor Liver Transplantation, Transplantation Proceedings, 2009, 41, 5, 1976
- 24, , Sildenafil monotherapy in portopulmonary hypertension can facilitate liver transplantation, Liver Transplantation, 2009, 15, 1Direct Link:
- 25, , Sildenafil therapy is associated with improved hemodynamics in liver transplantation candidates with pulmonary arterial hypertension, Liver Transplantation, 2009, 15, 1Direct Link:
- 26
- 27, , , , , , Liver transplantation for pulmonary vascular complications of pediatric end-stage liver disease, Journal of Pediatric Surgery, 2008, 43, 10, 1813
- 28, , , , , Survival in Portopulmonary Hypertension: Mayo Clinic Experience Categorized by Treatment Subgroups, American Journal of Transplantation, 2008, 8, 11Direct Link:
- 29, , , , Tratamiento de la hipertensión arterial pulmonar. Estrategias terapéuticas. Fármacos. Criterios de empleo. Indicaciones. Contraindicaciones. PosologÃa. Efectos secundarios. Criterios de asociación y sustitución, Medicine - Programa de Formación Médica Continuada Acreditado, 2008, 10, 23, 1566
- 30, , , Vascular actions of the prostacyclin receptor antagonist BAY 73-1449 in the portal hypertensive rat, European Journal of Pharmacology, 2008, 590, 1-3, 322
- 31
- 32, , , Assessment and treatment of pulmonary arterial hypertension: an Australian perspective in 2006, Internal Medicine Journal, 2007, 37, 1Direct Link:
- 33, , , , , , , , Assessment of acute pulmonary vascular reactivity in portopulmonary hypertension, Liver Transplantation, 2007, 13, 11Direct Link:
- 34, , Epidemiology of Pulmonary Arterial Hypertension, Clinics in Chest Medicine, 2007, 28, 1, 1
- 35, Liver transplantation and pulmonary hypertension: pathophysiology and management strategies, Current Opinion in Organ Transplantation, 2007, 12, 3, 274
- 36, , , , Long-term follow-up of portopulmonary hypertension: Effect of treatment with epoprostenol, Liver Transplantation, 2007, 13, 6Direct Link:
- 37
- 38, , Preoperative evaluation of patients with liver disease, Nature Clinical Practice Gastroenterology & Hepatology, 2007, 4, 5, 266
- 39, , Pretransplant Management of the Cirrhotic Patient, Clinics in Liver Disease, 2007, 11, 2, 431
- 40, , Prostanoid Therapy for Pulmonary Arterial Hypertension, Clinics in Chest Medicine, 2007, 28, 1, 127
- 41, , , , , , , , , , , , Rapid Switch From Intravenous Epoprostenol to Intravenous Treprostinil in Patients With Pulmonary Arterial Hypertension, Journal of Cardiovascular Pharmacology, 2007, 49, 1, 1
- 42, , , , , , , , The Impact of Treatment of Portopulmonary Hypertension on Survival Following Liver Transplantation, American Journal of Transplantation, 2007, 7, 5Direct Link:
- 43, , , , Traitement médical de l'hypertension artérielle pulmonaire, Annales de Cardiologie et d'Angéiologie, 2007, 56, S123
- 44, , , , Bosentan treatment of portopulmonary hypertension related to liver cirrhosis owing to hepatitis C, European Journal of Clinical Investigation, 2006, 36,Direct Link:
- 45, , , , , Efficiency and safety of bosentan in child C cirrhosis with portopulmonary hypertension and renal insufficiency, European Journal of Gastroenterology & Hepatology, 2006, 18, 10, 1117
- 46, , , Endothelin and endothelin receptor antagonism in portopulmonary hypertension, European Journal of Clinical Investigation, 2006, 36,Direct Link:
- 47, , , , , , , Hypertension portopulmonaire, Revue des Maladies Respiratoires, 2006, 23, 6, 629
- 48, , , , Model for end-stage liver disease (MELD) exception for portopulmonary hypertension, Liver Transplantation, 2006, 12, S3Direct Link:
- 49
- 50
- 51, Portopulmonary Hypertension and Hepatopulmonary Syndrome, and Liver Transplantation, International Anesthesiology Clinics, 2006, 44, 3, 69
- 52, , , , , , , , , , , , Portopulmonary Hypertension in the Early Phase Following Liver Transplantation, Transplantation, 2006, 82, 7, 887
- 53, , Pulmonary hypertension and β-thalassemia major: Report of a case, its treatment, and a review of the literature, American Journal of Hematology, 2006, 81, 6Direct Link:
- 54, , , , , Sildenafil decreased pulmonary arterial pressure but may have exacerbated portal hypertension in a patient with cirrhosis and portopulmonary hypertension, Journal of Gastroenterology, 2006, 41, 6, 593
- 55, , , , , , , , , Successful Liver Transplantation Following Medical Management of Portopulmonary Hypertension: A Single-Center Series, American Journal of Transplantation, 2006, 6, 9Direct Link:
- 56, , Successful treatment of portopulmonary hypertension with bosentan: case report, European Journal of Clinical Investigation, 2006, 36,Direct Link:
- 57, , The pulmonary involvement in portal hypertension: portopulmonary hypertension and hepatopulmonary syndrome, GastroenterologÃa y HepatologÃa, 2006, 29, 1, 40
- 58
- 59
- 60, , , Advances in the Medical Treatment of Pulmonary Hypertension, Kidney and Blood Pressure Research, 2005, 28, 5-6, 311
- 61, , , Anomalies pulmonaires au cours des maladies hépatiques, EMC - Pneumologie, 2005, 2, 1, 49
- 62, Bosentan for the treatment of pulmonary arterial hypertension (II), Therapy, 2005, 2, 6, 849
- 63, Bosentan for the treatment of pulmonary arterial hypertension (II), Therapy, 2005, 2, 6, 849
- 64, , , , , Correlation between Right Ventricular Indices and Clinical Improvement in Epoprostenol Treated Pulmonary Hypertension Patients, Echocardiography, 2005, 22, 5Direct Link:
- 65GuÃas de Práctica ClÃnica sobre el diagnóstico y tratamiento de la hipertensión arterial pulmonar, Revista Española de CardiologÃa, 2005, 58, 5, 523
- 66GuÃas de Práctica ClÃnica sobre el diagnóstico y tratamiento de la hipertensión arterial pulmonar, Revista Española de CardiologÃa (English Edition), 2005, 58, 5, 523
- 67, , , , , , , Hemodynamics and survival of patients with portopulmonary hypertension, Liver Transplantation, 2005, 11, 9Direct Link:
- 68, Hepatopulmonary Syndrome and Portopulmonary Hypertension: Implications for Liver Transplantation, Clinics in Chest Medicine, 2005, 26, 4, 587
- 69, Issues affecting liver transplantation, Best Practice & Research Clinical Anaesthesiology, 2005, 19, 1, 17
- 70, , , Les traitements de l’hypertension artérielle pulmonaire à l’heure de la T2A. Recommandations du groupe de travail “Maladies vasculaires pulmonaires†de la Société de pneumologie de langue française, La Presse Médicale, 2005, 34, 19, 1456
- 71, , , , , , Liver Transplantation in High-Risk Patients: Hepatopulmonary Syndrome and Portopulmonary Hypertension, Transplantation Proceedings, 2005, 37, 9, 3861
- 72, , Management of pre–liver transplantation patient—Part 2, Liver Transplantation, 2005, 11, 3Direct Link:
- 73
- 74, , Medical therapeutics for pulmonary arterial hypertension: from basic science and clinical trial design to evidence-based medicine, Expert Review of Cardiovascular Therapy, 2005, 3, 2, 347
- 75, Portopulmonary hypertension and the issue of survival, Liver Transplantation, 2005, 11, 9Direct Link:
- 76, , , , , , Successful Liver Transplantation in a Child with Severe Portopulmonary Hypertension Treated with Epoprostenol, Journal of Pediatric Gastroenterology and Nutrition, 2005, 41, 4, 466
- 77
- 78
- 79, Classification and epidemiology of pulmonary hypertension, Cardiology Clinics, 2004, 22, 3, 327
- 80, , , , , , , , , , , Hepatopulmonary syndrome and portopulmonary hypertension: A report of the multicenter liver transplant database, Liver Transplantation, 2004, 10, 2Direct Link:
- 81
- You have free access to this content82, , , Medical Management of Porto-Pulmonary Hypertension and Right Heart Failure Prior to Living-Related Liver Transplantation, Congestive Heart Failure, 2004, 10, 4Direct Link:
- 83, , , Portopulmonary hypertension and hepatopulmonary syndrome, The Lancet, 2004, 363, 9419, 1461
- 84, Prise en charge de l’hypertension porto-pulmonaire, Gastroentérologie Clinique et Biologique, 2004, 28, 169
- 85, Prise en charge thérapeutique de l’hypertension porto-pulmonaire, Gastroentérologie Clinique et Biologique, 2004, 28, 312
- 86, Prise en charge thérapeutique de l’hypertension porto-pulmonaire, Revue des Maladies Respiratoires, 2004, 21, 3, 637
- 87, , , , SUCCESSFUL TREATMENT OF SEVERE PORTOPULMONARY HYPERTENSION AFTER LIVER TRANSPLANTATION BY BOSENTAN, Transplantation, 2004, 77, 11, 1774
- 88, , Critical care of the liver transplant patient: an update, Current Opinion in Critical Care, 2002, 8, 2, 178
- 89, Hepatopulmonary syndrome and portopulmonary hypertension, Current Treatment Options in Cardiovascular Medicine, 2002, 4, 3, 267
- 90, Hepatopulmonary syndrome and portopulmonary hypertension, Current Treatment Options in Gastroenterology, 2001, 4, 6, 539
- 91, , REGIONAL AND SYSTEMIC HEMODYNAMIC DISTURBANCES IN CIRRHOSIS, Clinics in Liver Disease, 2001, 5, 3, 617
- 92, , , , , , RISK FACTORS FOR PULMONARY ARTERIAL HYPERTENSION, Clinics in Chest Medicine, 2001, 22, 3, 459
- 93
- 94, , , Management of urgent high-risk cardiopulmonary bypass in patients with heparin-induced thrombocytopenia type II and coexisting disorders of renal function: Use of heparin and epoprostenol combined with on-line monitoring of platelet function, Journal of Cardiothoracic and Vascular Anesthesia, 2000, 14, 3, 304
- 95
- 96